Clinical Trial Update: ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs [Phase 2]

View source ↗

Summary

The ASCEND trial is a Phase 2 study evaluating the safety and effectiveness of VIA Disc NP for degenerative disc disease, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Disc Degeneration
• Lumbar Discogenic Pain

Drugs mentioned

• VIA Disc NP

Snippet

Sponsor: VIVEX Biologics, Inc. | Conditions: Degenerative Disc Disease, Disc Degeneration | Phase 2 | Status: RECRUITING